MIRA PHARMACEUTICALS INC (MIRA) Stock Price, Quote, News and Overview
NASDAQ:MIRA - Nasdaq - US60458C1045 - Common Stock - Currency: USD
MIRA Quote, Performance and Key Statistics
1.03
-0.01 (-0.96%)
The current stock price of MIRA is 1.03 USD. In the past month the price decreased by -2.83%. In the past year, price increased by 40.52%.
MIRA Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 67.48 | 831.66B | ||
| JNJ | JOHNSON & JOHNSON | 15.46 | 374.37B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 18.15 | 277.97B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 14.19 | 222.45B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 16.85 | 216.81B | ||
| MRK | MERCK & CO. INC. | 10.68 | 209.34B | ||
| PFE | PFIZER INC | 7.41 | 130.73B | ||
| SNY | SANOFI-ADR | 13.7 | 129.16B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 6.6 | 98.60B | ||
| GSK | GSK PLC-SPON ADR | 8.75 | 77.12B | ||
| ZTS | ZOETIS INC | 25.94 | 68.50B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 32.96 | 47.71B |
Related stock screener links
About MIRA
Company Profile
Mira Pharmaceuticals Inc is a US-based company operating in Pharmaceuticals industry. The company is headquartered in Miami, Florida. The company went IPO on 2023-08-03. MIRA Pharmaceuticals, Inc. is a clinical-stage pharmaceutical development company. The firm has two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive license rights in the United States, Canada and Mexico for Ketamir-2 and MIRA-55, two novel drug candidates designed to address unmet medical needs in pain management, depression, PTSD and cognitive function. Ketamir-2 is a patent-pending oral ketamine analog evaluated for the treatment of diabetic neuropathy and is in an ongoing Phase I clinical trial. The company is for patients suffering from neuropathic pain, treatment-resistant depression (TRD), major depressive disorder with suicidal ideation (MDD-SI), and post-traumatic stress disorder (PTSD). MIRA-55 is a preclinical-stage investigational drug designed to support cognitive function and enhance memory. The company is for the treatment of patients experiencing cognitive decline, including those with early neurodegenerative conditions.
Company Info
MIRA PHARMACEUTICALS INC
1200 Brickell Avenue, Suite 1950 #1183
Miami FLORIDA US
Employees: 3
Company Website: https://mirapharmaceuticals.com/
Investor Relations: https://www.mirapharmaceuticals.com/investors
Phone: 18133695150
MIRA PHARMACEUTICALS INC / MIRA FAQ
What is the stock price of MIRA PHARMACEUTICALS INC today?
The current stock price of MIRA is 1.03 USD. The price decreased by -0.96% in the last trading session.
What is the ticker symbol for MIRA PHARMACEUTICALS INC stock?
The exchange symbol of MIRA PHARMACEUTICALS INC is MIRA and it is listed on the Nasdaq exchange.
On which exchange is MIRA stock listed?
MIRA stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for MIRA PHARMACEUTICALS INC stock?
6 analysts have analysed MIRA and the average price target is 14.66 USD. This implies a price increase of 1323.54% is expected in the next year compared to the current price of 1.03. Check the MIRA PHARMACEUTICALS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is MIRA PHARMACEUTICALS INC worth?
MIRA PHARMACEUTICALS INC (MIRA) has a market capitalization of 17.31M USD. This makes MIRA a Nano Cap stock.
How many employees does MIRA PHARMACEUTICALS INC have?
MIRA PHARMACEUTICALS INC (MIRA) currently has 3 employees.
What are the support and resistance levels for MIRA PHARMACEUTICALS INC (MIRA) stock?
MIRA PHARMACEUTICALS INC (MIRA) has a support level at 1.03 and a resistance level at 1.04. Check the full technical report for a detailed analysis of MIRA support and resistance levels.
Should I buy MIRA PHARMACEUTICALS INC (MIRA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of MIRA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of MIRA, evaluating the profitability, health, valuation and growth aspects
- MIRA PHARMACEUTICALS INC (MIRA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- MIRA PHARMACEUTICALS INC (MIRA) Sales and EPS estimates to see what analysts future expectations are.
- MIRA PHARMACEUTICALS INC (MIRA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- MIRA PHARMACEUTICALS INC (MIRA) Insider and Institutional Ownership to learn about the owners and their transactions.
- MIRA PHARMACEUTICALS INC (MIRA) Stock Chart to make your own analysis
- MIRA PHARMACEUTICALS INC (MIRA) Latest news and press-releases to stay up to date.
Does MIRA PHARMACEUTICALS INC (MIRA) stock pay dividends?
MIRA does not pay a dividend.
What is the Price/Earnings (PE) ratio of MIRA PHARMACEUTICALS INC (MIRA)?
MIRA PHARMACEUTICALS INC (MIRA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.52).
What is the Short Interest ratio of MIRA PHARMACEUTICALS INC (MIRA) stock?
The outstanding short interest for MIRA PHARMACEUTICALS INC (MIRA) is 4.27% of its float. Check the ownership tab for more information on the MIRA short interest.
MIRA Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to MIRA. When comparing the yearly performance of all stocks, MIRA is one of the better performing stocks in the market, outperforming 88.11% of all stocks.
MIRA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to MIRA. MIRA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
MIRA Financial Highlights
Over the last trailing twelve months MIRA reported a non-GAAP Earnings per Share(EPS) of -0.52. The EPS increased by 42.02% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -268.64% | ||
| ROE | -356.97% | ||
| Debt/Equity | 0 |
MIRA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 43% to MIRA. The Buy consensus is the average rating of analysts ratings from 6 analysts.